Whereas initially the high ACTH led to the suspicion of primary adrenal insufficiency, the reduced potency of ACTH at the MC2R/MRAP shows that there is actually a secondary adrenal insufficiency. The gene discussed is MRAP; the disease is primary adrenal insufficiency.